Prospective Study Clinical Trial
Official title:
A Multicenter Prospective Follow-up Study on the Effect of Histological Remission on the Clinical Prognosis of Ulcerative Colitis
Mucosal healing or histological remission is an important target for the treatment of inflammatory bowel disease. In this study, patients with mucosal healing are defined as a control group, observing their clinical outcomes for 3 years, and describing the recurrence rate. The secondary objective is to study the operative rate, glucocorticoid utilization rate, treatment escalation rate, hospitalization rate and incidence of related complications.
Assess the health condition of patients for 1year, 2year,3year and analyze outcomes and complications. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01257399 -
Comparative Efficacy and Safety Study in Patients With Ulcerative Colitis in Remission Phase
|
Phase 3 | |
| Completed |
NCT01301976 -
Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis
|
N/A | |
| Terminated |
NCT03122613 -
Curcumin for Prevention of Relapse in Patients With Ulcerative Colitis
|
N/A | |
| Recruiting |
NCT03501758 -
Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound
|
||
| Recruiting |
NCT04695964 -
Objective Perfusion Rate Assessment by Near-infrared Fluorescence in Ileal Pouch Formation and Ileal-pouch-anal Anastomosis
|
N/A | |
| Completed |
NCT05656391 -
Impact of Bread Diet on Intestinal Dysbiosis and Irritable Bowel Syndrome Symptoms in Quiescent Ulcerative Colitis
|
N/A |